Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mTOR Signalling Pathway in Human Cancer
Helena Pópulo, José Manuel Lopes, Paula Soares
International Journal of Molecular Sciences (2012) Vol. 13, Iss. 2, pp. 1886-1918
Open Access | Times Cited: 774

Showing 1-25 of 774 citing articles:

The Roles of Autophagy in Cancer
Chul Won Yun, Sang Hun Lee
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3466-3466
Open Access | Times Cited: 858
Melanoma treatment in review
Beatriz Domingues, José Manuel Lopes, Paula Soares, et al.
ImmunoTargets and Therapy (2018) Vol. Volume 7, pp. 35-49
Open Access | Times Cited: 606
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Dudley W. Lamming, Lan Ye, David M. Sabatini, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 3, pp. 980-989
Open Access | Times Cited: 488
Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
Véronique Nogueira, Nissim Hay
Clinical Cancer Research (2013) Vol. 19, Iss. 16, pp. 4309-4314
Open Access | Times Cited: 474
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 466
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Michael Orth, Philipp Metzger, S. Gerum, et al.
Radiation Oncology (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 400
Nutrient signaling to mTOR and cell growth
Jenna L. Jewell, Kun‐Liang Guan
Trends in Biochemical Sciences (2013) Vol. 38, Iss. 5, pp. 233-242
Open Access | Times Cited: 378
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 343
High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation
Olha Zhenyukh, Esther Civantos, Marta Ruíz-Ortega, et al.
Free Radical Biology and Medicine (2017) Vol. 104, pp. 165-177
Open Access | Times Cited: 320
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells
Katayoon Pakravan, Sadegh Babashah, Majid Sadeghizadeh, et al.
Cellular Oncology (2017) Vol. 40, Iss. 5, pp. 457-470
Closed Access | Times Cited: 311
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways
Lei Chang, Peter Graham, Jingli Hao, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 10, pp. e1437-e1437
Open Access | Times Cited: 282
mTOR Pathways in Cancer and Autophagy
Mathieu Paquette, Leeanna El–Houjeiri, Arnim Pause
Cancers (2018) Vol. 10, Iss. 1, pp. 18-18
Open Access | Times Cited: 271
Aiding and abetting roles of NOX oxidases in cellular transformation
Karen Block, Yves Gorin
Nature reviews. Cancer (2012) Vol. 12, Iss. 9, pp. 627-637
Open Access | Times Cited: 270
Organelle targeting: third level of drug targeting
Harish Padh, Niraj Sakhrani
Drug Design Development and Therapy (2013), pp. 585-585
Open Access | Times Cited: 259
CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling
Yunliang Wang, Yutong Wang, Jinfeng Li, et al.
Cancer Letters (2015) Vol. 367, Iss. 2, pp. 122-128
Closed Access | Times Cited: 251
tsRNA signatures in cancer
Veronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 30, pp. 8071-8076
Open Access | Times Cited: 248
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
Xiaojie Xu, Zhongyi Fan, Lei Kang, et al.
Journal of Clinical Investigation (2013)
Open Access | Times Cited: 247
Cellular Entry of Human Papillomavirus Type 16 Involves Activation of the Phosphatidylinositol 3-Kinase/Akt/mTOR Pathway and Inhibition of Autophagy
Zurab Surviladze, Rosa T. Sterk, Sergio A. DeHaro, et al.
Journal of Virology (2012) Vol. 87, Iss. 5, pp. 2508-2517
Open Access | Times Cited: 217
Novel targeted therapies and immunotherapy for advanced thyroid cancers
George E. Naoum, Michael Morkos, Brian W. Kim, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 209
Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth
Bodo C. Melnik, Swen Malte John, Gerd Schmitz
Nutrition Journal (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 203
mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
Karen Griselda de la Cruz-López, Mariel Esperanza Toledo Guzmán, Elizabeth Sánchez, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 181
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
Jean Christopher Chamcheu, Tithi Roy, Mohammad B. Uddin, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 803-803
Open Access | Times Cited: 161
Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy
Xing Guo, Wei Xiao, Zi Chen, et al.
Progress in Materials Science (2019) Vol. 107, pp. 100599-100599
Closed Access | Times Cited: 157
Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin
Pooja Sharma, Sarah Alsharif, Arwa Fallatah, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 497-497
Open Access | Times Cited: 150
Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis
Xingchen Li, Jianliu Wang
International Journal of Biological Sciences (2020) Vol. 16, Iss. 12, pp. 2014-2028
Open Access | Times Cited: 146
Page 1 - Next Page

Scroll to top